Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/178650
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBazinet, Alexandre-
dc.contributor.authorHeath, John-
dc.contributor.authorChong, Anne-Sophie-
dc.contributor.authorSimo-Cheyou, Estelle R.-
dc.contributor.authorWorme, Samantha-
dc.contributor.authorRivera, Barbara-
dc.contributor.authorFoulkes, William D.-
dc.contributor.authorCaplan, Stephen-
dc.contributor.authorJohnson, Nathalie A.-
dc.contributor.authorOrthwein, Alexandre-
dc.contributor.authorMercier, François E.-
dc.date.accessioned2021-06-28T10:46:46Z-
dc.date.available2021-06-28T10:46:46Z-
dc.date.issued2021-05-13-
dc.identifier.urihttp://hdl.handle.net/2445/178650-
dc.description.abstractHematological malignancies are broadly divided into myeloid and lymphoid neoplasms, reflecting the two major cellular lineages of the hematopoietic system. It is generally rare for hematological malignancies to spontaneously progress with a switch from myeloid to lymphoid lineage. We describe the exceptional case of a patient who sequentially developed myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), and B-cell acute lymphoblastic leukemia (B-ALL), as well as our investigation into the underlying pathogenesis. Using whole-exome sequencing (WES) performed on sorted CMML and B-ALL cell fractions, we identified both common and unique potential driver mutations, suggesting a branching clonal evolution giving rise to both diseases. Interestingly, we also identified a germline variant in the cancer susceptibility gene CHEK2 We validated that this variant (c.475T > C; p.Y159H), located in the forkhead-associated (FHA) domain, impairs its capacity to bind BRCA1 in cellulo. This unique case provides novel insight into the genetics of complex hematological diseases and highlights the possibility that such patients may carry inherited predispositions.-
dc.format.extent13 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherCold Spring Harbor Laboratory-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1101/mcs.a006090-
dc.relation.ispartofMolecular Case Studies, 2021-
dc.relation.urihttps://doi.org/10.1101/mcs.a006090-
dc.rightscc by-nc (c) Bazinet et al., 2021-
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subject.classificationMalalties hematològiques-
dc.subject.classificationEpigenètica-
dc.subject.classificationLeucèmia-
dc.subject.otherHematologic diseases-
dc.subject.otherEpigenetics-
dc.subject.otherLeukemia-
dc.titleCommon clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline CHEK2 variant-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2021-06-25T07:54:26Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Stud-2021-Bazinet-a006090.pdf3.55 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons